BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Glycopyrronium (PT001) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Glycopyrronium (PT001)\, from ClinicalTri
 als.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07525375-4297@assetmemo.bio
DTSTAMP:20261121T005016Z
DTSTART;VALUE=DATE:20290523
DTEND;VALUE=DATE:20290524
SUMMARY:Glycopyrronium (PT001): Phase 2 readout est. (NCT07525375)
DESCRIPTION:Glycopyrronium (PT001)\, phase 2\, Asthma.\nStudy: A Phase II S
 tudy to Investigate Lung Function With 2 Different Doses of Inhaled Glycop
 yrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 
 12 Years of Age With Asthma\nEstimated primary completion: 23 May 2029. Th
 is is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and i
 t can move.\nDrug page: https://assetmemo.bio/drug/glycopyrronium-pt001#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT075253
 75
URL:https://assetmemo.bio/drug/glycopyrronium-pt001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
